{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:55:36Z","timestamp":1794707736912,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Glycogen storage diseases (GSDs) with liver involvement are classified into subtypes\u2014types 0, Ia, and Ib; III, IV, VI, IX, and XIa, XIb, and XIc, depending on the deficient enzyme. Hypoglycemia and hepatomegaly (except type 0) are hallmarks of the disease; however, muscular and renal tubular involvement, dyslipidemia, and osteopenia can occur. The present study was conducted to highlight the clinical differences and characteristics between types, complications, and long-term outcomes in patients with hepatic GSD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>The records of 132 patients with hepatic GSD, confirmed through genetic analysis, were retrospectively reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 132 patients, 55.3% were male. The consanguinity rate was 75, and 53% of the patients had a family history. The age at diagnosis was 34.36\u2009\u00b1\u200935.1\u00a0months. The frequency distribution was as follows: GSD type III (42.4%), Ia (17.4%), IXa (9.1%), Ib (9.1%), IXc (7.6%), VI (6.8%), IXb (4.5%), IV (2.3%), and 0 (0.8%). The most common presenting symptoms were abdominal distention (40.9%), elevated liver transaminases (14.4%), hepatomegaly (13.6%), hypoglycemia (12.1%), family screening (12.1%), growth retardation (4%), and others (3.8%). Hepatomegaly was found in 84.9%, splenomegaly in 20.5%, short stature in 46.2%, underweight in 14.4%, and obesity in 13.5% of the patients. Non-hepatic malignancy was detected in three patients with GSD type III. The twin rate was 6.1%. The rate of short stature was 46.2% at the time of diagnosis, while it was 15.4% in patients who reached adulthood. The number of twin patients was higher than reported in the literature, and structural anomalies such as intestinal duplication cyst, renal artery stenosis, and pulmonary stenosis, which were not previously reported in association with GSD, along with non-hepatic malignancy, were notable findings in our study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Liver glycogenosis can present distinct and similar clinical, laboratory, and radiological features, challenging differential diagnosis between types. Our study may guide diagnosing and monitoring common GSDs with hepatic involvement.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03783-4","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:17:03Z","timestamp":1754324223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical features and rare complications in 132 patients with hepatic glycogenosis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-0500","authenticated-orcid":false,"given":"Deniz","family":"Kor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Derya","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"K\u00f6\u015feci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Burga\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazmiye","family":"T\u00fczel G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halise Neslihan","family":"\u00d6nenli Mungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"3783_CR1","first-page":"497","volume":"82","author":"E von Gierke","year":"1929","unstructured":"von Gierke E. Hepato-nephromegalia glykogenica (Glykogenspeicher-krankheit der Leber und Nieren). Beitr Path Anat. 1929;82:497\u2013513.","journal-title":"Beitr Path Anat"},{"key":"3783_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13023-020-01573-8","volume":"15","author":"Z Beyzaei","year":"2020","unstructured":"Beyzaei Z, Geramizadeh B, Karimzadeh S. Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature (2020). Orphanet J Rare Dis. 2020;15:286.","journal-title":"Orphanet J Rare Dis"},{"key":"3783_CR3","first-page":"30","volume":"18","author":"Z Beyzaei","year":"2019","unstructured":"Beyzaei Z, Geramizadeh B. Molecular diagnosis of glycogen storage disease type I: a review. EXCLI J. 2019;18:30\u201346.","journal-title":"EXCLI J"},{"key":"3783_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/gim.2012.104","volume":"15","author":"J Wang","year":"2013","unstructured":"Wang J, Cui H, Lee NC, Hwu WL, Chien YH, Craigen WJ, et al. Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med. 2013;15:106\u201314.","journal-title":"Genet Med"},{"key":"3783_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/advances\/nmz092","volume":"11","author":"KM Ross","year":"2020","unstructured":"Ross KM, Ferrecchia IA, Dahlberg KR, Dambska M, Ryan PT, Weinstein DA. Dietary management of the glycogen storage diseases: evolution of treatment and ongoing controversies. Adv Nutr. 2020;11:439\u201346.","journal-title":"Adv Nutr"},{"key":"3783_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-802896-4.00013-4","volume-title":"Biomarkers in inborn errors of metabolism","author":"AM Ferguson","year":"2017","unstructured":"Ferguson AM. Carbohydrate disorders. In: Garg U, Smith LD, editors. Biomarkers in inborn errors of metabolism. 1st ed. Elsevier: Amsterdam; 2017. p. 155\u201366.","edition":"1"},{"key":"3783_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1750-1172-6-27","volume":"6","author":"R Froissart","year":"2011","unstructured":"Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, et al. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis. 2011;6:27.","journal-title":"Orphanet J Rare Dis"},{"key":"3783_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1023\/A:1021831621210","volume":"4","author":"JI Wolfsdorf","year":"2003","unstructured":"Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord. 2003;4:95\u2013102.","journal-title":"Rev Endocr Metab Disord"},{"key":"3783_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJM198401193100306","volume":"310","author":"YT Chen","year":"1984","unstructured":"Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen-storage disease. N Engl J Med. 1984;310:171\u20135.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"3783_CR10","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/BF02679990","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. European study on glycogen storage disease Type I (ESGSD I) Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease Type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl 1):S20-34.","journal-title":"Eur J Pediatr"},{"issue":"Suppl 2","key":"3783_CR11","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/PL00014320","volume":"158","author":"D Matern","year":"1999","unstructured":"Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr. 1999;158(Suppl 2):S43\u20138.","journal-title":"Eur J Pediatr"},{"key":"3783_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/lt.21151","volume":"13","author":"SG Iyer","year":"2007","unstructured":"Iyer SG, Chen CL, Wang CC, Wang SH, Concejero AM, Liu YW, et al. Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl. 2007;13:848\u201352.","journal-title":"Liver Transpl"},{"key":"3783_CR13","first-page":"1","volume":"51","author":"O Neyzi","year":"2008","unstructured":"Neyzi O, Gunoz A, Furman A, Bundak R, G\u00f6k\u00e7ay G, Darendeliler F, et al. T\u00fcrk \u00c7ocuklar\u0131nda v\u00fccut a\u011f\u0131rl\u0131\u011f\u0131, boy uzunlu\u011fu, ba\u015f \u00e7evresi ve v\u00fccut kitle indeksi referans de\u011ferleri. \u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Dergisi. 2008;51:1\u201314.","journal-title":"\u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Dergisi"},{"key":"3783_CR14","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","volume":"29","author":"E G\u00fcm\u00fc\u015f","year":"2023","unstructured":"G\u00fcm\u00fc\u015f E, \u00d6zen H. Glycogen storage diseases: an update. World J Gastroenterol. 2023;29:3932\u201363.","journal-title":"World J Gastroenterol"},{"key":"3783_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/jhg.2013.17","volume":"58","author":"J Kido","year":"2013","unstructured":"Kido J, Nakamura K, Matsumoto S, Mitsubuchi H, Ohura T, Shigematsu Y, et al. Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes. J Hum Genet. 2013;58:285\u201392.","journal-title":"J Hum Genet"},{"key":"3783_CR16","doi-asserted-by":"publisher","first-page":"5870092","DOI":"10.1155\/2022\/5870092","volume":"2022","author":"SA Abdul Wahab","year":"2022","unstructured":"Abdul Wahab SA, Yakob Y, Mohd Khalid MKN, Ali N, Leong HY, Ngu LH. Molecular, biochemical, and clinical characterization of thirteen patients with glycogen storage disease 1a in Malaysia. Genet Res (Camb). 2022;2022:5870092.","journal-title":"Genet Res (Camb)"},{"key":"3783_CR17","first-page":"373","volume":"35","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Akbar F, Ali AJ, Afroze B. Clinical, pathological and molecular spectrum of patients with glycogen storage diseases in Pakistan. J Pediatr Endocrinol Metab. 2022;35:373\u201385.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3783_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/ped.14286","volume":"62","author":"NE \u00c7akar","year":"2020","unstructured":"\u00c7akar NE, Gezdirici A, Topuz H, \u00d6nal H. Novel variants in Turkish patients with glycogen storage disease. Pediatr Int. 2020;62:1145\u201350.","journal-title":"Pediatr Int"},{"key":"3783_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4274\/tpa.185","volume":"48","author":"FT Eminoglu","year":"2013","unstructured":"Eminoglu FT, T\u00fcmer L, Okur \u0130, Ezg\u00fc FS, Hasanoglu A. Clinical course and outcome of glycogen-storage disease type 1a and type 1b. Turk Pediatri Ar\u015fivi. 2013;48:117\u201322.","journal-title":"Turk Pediatri Ar\u015fivi"},{"key":"3783_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1444","volume":"8","author":"Y Liang","year":"2020","unstructured":"Liang Y, Du C, Wei H, Zhang C, Zhang M, Hu M, et al. Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases. Mol Genet Genomic Med. 2020;8: e1444.","journal-title":"Mol Genet Genomic Med"},{"key":"3783_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/genes12081205","volume":"12","author":"SC Gr\u00fcnert","year":"2021","unstructured":"Gr\u00fcnert SC, Hannibal L, Spiekerkoetter U. The phenotypic and genetic spectrum of glycogen storage disease type VI. Genes. 2021;12:1205.","journal-title":"Genes"},{"key":"3783_CR22","unstructured":"T\u00fcrkiye \u0130statistik Kurumu (TU\u0130K), Do\u011fum istatistikleri (2023). https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Dogum-Istatistikleri-2023-53708"},{"key":"3783_CR23","doi-asserted-by":"publisher","first-page":"e20200028","DOI":"10.1590\/2326-4594-jiems-2020-0028","volume":"9","author":"V Bindi","year":"2021","unstructured":"Bindi V, Eiroa H, Crespo CL, Mart\u00ednez M\u00c1, Bay LB. Clinical, biochemical and molecular characterization of a cohort of glycogen storage disease type i patients in a high complexity hospital in Argentina. J Inborn Errors Metab Screen. 2021;9:e20200028.","journal-title":"J Inborn Errors Metab Screen."},{"key":"3783_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1023\/A:1026777106212","volume":"23","author":"M Goto","year":"2000","unstructured":"Goto M, Taki T, Sugie H, Miki Y, Kato H, Hayashi Y. A novel mutation in the glucose-6-phosphatase gene in Korean twins with glycogen storage disease type Ia. J Inherit Metab Dis. 2000;23:851\u20132.","journal-title":"J Inherit Metab Dis"},{"key":"3783_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1550059413500276","volume":"45","author":"S Kroczka","year":"2014","unstructured":"Kroczka S, Biedro\u0144 A, Kaci\u0144ski M. Epilepsy and electrophysiological findings in polish twins with glycogenosis type IIIb. Clin EEG Neurosci. 2014;45:201\u20134.","journal-title":"Clin EEG Neurosci"},{"key":"3783_CR26","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2021\/39\/2020046","volume":"39","author":"NB Jorge","year":"2021","unstructured":"Jorge NB, Tommaso AMA, Hessel G. Anthropometric and dietary assessment of patients with glycogenosis type I. Rev Paul Pediatr. 2021;39: e2020046.","journal-title":"Rev Paul Pediatr"},{"key":"3783_CR27","volume":"29","author":"G Hijazi","year":"2021","unstructured":"Hijazi G, Paschall A, Young SP, Smith B, Case LE, Boggs T, et al. A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III. Mol Genet Metab Rep. 2021;29: 100821.","journal-title":"Mol Genet Metab Rep"},{"key":"3783_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ymgme.2020.10.004","volume":"131","author":"SA Fernandes","year":"2020","unstructured":"Fernandes SA, Cooper GE, Gibson RA, Kishnani PS. Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX. Mol Genet Metab. 2020;131:299\u2013305.","journal-title":"Mol Genet Metab"},{"issue":"17","key":"3783_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13023-022-02431-5","volume":"19","author":"F Tagliaferri","year":"2022","unstructured":"Tagliaferri F, Massese M, Russo L, Commone A, Gasperini S, Pretese R, et al. Hepatic glycogen storage diseases type 0, VI and IX: description of an italian cohort. Orphanet J Rare Dis. 2022;19(17):285.","journal-title":"Orphanet J Rare Dis"},{"key":"3783_CR30","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/ijms22094381","volume":"22","author":"A Molares-Vila","year":"2021","unstructured":"Molares-Vila A, Corbal\u00e1n-Rivas A, Carnero-Gregorio M, Gonz\u00e1lez-Cesp\u00f3n JL, Rodr\u00edguez-Cerdeira C. Biomarkers in glycogen storage diseases: an update. Int J Mol Sci. 2021;22:4381.","journal-title":"Int J Mol Sci"},{"key":"3783_CR31","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16:e1-29.","journal-title":"Genet Med"},{"key":"3783_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5114\/pedm.2022.116115","volume":"28","author":"M Kaczor","year":"2022","unstructured":"Kaczor M, Wes\u00f3\u0142-Kucharska D, Greczan M, Kierus K, Ka\u0142u\u017cny \u0141, Du\u015b-\u017buchowska M, et al. Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in Poland. Pediatr Endocrinol Diabetes Metab. 2022;28:207\u2013112.","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"3783_CR33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1515\/jpem-2020-0173","volume":"33","author":"S-Q Lu","year":"2020","unstructured":"Lu S-Q, Feng J-Y, Liu J, Xie X-B, Lu Y, Abuduxikuer K. Glycogen storage disease type VI can progress to cirrhosis: ten Chinese patients with GSD VI and a literature review. J Pediatr Endocrinol Metab. 2020;33:1321\u201333.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3783_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1515\/jpem-2016-0317","volume":"30","author":"\u00c7S Kasapkara","year":"2017","unstructured":"Kasapkara \u00c7S, Aycan Z, A\u00e7o\u011flu E, Senel S, Oguz MM, Ceylaner S. The variable clinical phenotype of three patients with hepatic glycogen synthase deficiency. J Pediatr Endocrinol Metab. 2017;30:459\u201362.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3783_CR35","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/jcu.10008","volume":"29","author":"C Pozzato","year":"2001","unstructured":"Pozzato C, Botta A, Melgara C, Fiori L, Giann\u00ec ML, Riva E. Sonographic findings in type I glycogen storage disease. J Clin Ultrasound. 2001;29:456\u201361.","journal-title":"J Clin Ultrasound"},{"key":"3783_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13023-022-02431-5","volume":"17","author":"F Tagliaferri","year":"2022","unstructured":"Tagliaferri F, Massese M, Russo L, Commone A, Gasperini S, Pretese R, et al. Hepatic glycogen storage diseases type 0, VI and IX: description of an italian cohort. Orphanet J Rare Dis. 2022;17:285.","journal-title":"Orphanet J Rare Dis"},{"key":"3783_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12026-022-09320-w","volume":"71","author":"SE Meimand","year":"2023","unstructured":"Meimand SE, Azizi G, Yazdani R, Sanadgol N, Rezaei N. Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report. Immunol Res. 2023;71:107\u201311.","journal-title":"Immunol Res"},{"key":"3783_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13023-022-02284-y","volume":"17","author":"Z Beyzaei","year":"2022","unstructured":"Beyzaei Z, Shamsaeefar A, Kazemi K, Nikeghbalian S, Bahador A, Dehghani M, et al. Liver transplantation in glycogen storage disease: a single-center experience. Orphanet J Rare Dis. 2022;17:127.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03783-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03783-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03783-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:49:35Z","timestamp":1757339375000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03783-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3783"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03783-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University \u00c7ukurova (ID number: 125\/16.09.2022). Informed consent was obtained from all individual participants and the parents of all children included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}